Canada fears its clinical trial regulations hurt devices
This article was originally published in Clinica
Executive Summary
Health Canada (HC) is proposing changes to the national regulatory framework for investigational testing (IT) - clinical trials - of medical devices in order to better manage the associated risks and also to adopt the risk management approach that other regulators - including HC for drugs - already implement.